DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Issue 06 · Volume 32 · September 2006 DOI: 10.1055/s-002-5142 Hereditary von Willebrand Disease and Acquired von Willebrand Syndrome: Clinical Manifestations, Diagnosis, and Management Jan J Michiels M.D. Ph.D. Emmanuel J Favaloro Ph.D. M.A.I.M.S.

PREFACE

553
Mammen, Eberhard F.: Hereditary von Willebrand Disease and Acquired von Willebrand Syndrome: Clinical Manifestations, Diagnosis, and Management

555
Federici, Augusto B.: Diagnosis of Inherited von Willebrand Disease: A Clinical Perspective
566
Favaloro, Emmanuel J.: Laboratory Monitoring of Therapy in von Willebrand Disease: Efficacy of the PFA-100 and von Willebrand Factor:Collagen-Binding Activity as Coupled Strategies
577
Michiels, Jan J.; Berneman, Zwi; Gadisseur, Alain; van der Planken, Marc; Schroyens, Wilfried; Budde, Ulrich; van Vliet, Huub H. D. M.: Immune-Mediated Etiology of Acquired von Willebrand Syndrome in Systemic Lupus Erythematosus and in Benign Monoclonal Gammopathy: Therapeutic Implications
589
Michiels, Jan J.; Berneman, Zwi; Schroyens, Wilfried; Finazzi, Guido; Budde, Ulrich; van Vliet, Huub H. D. M.: The Paradox of Platelet Activation and Impaired Function: Platelet-von Willebrand Factor Interactions, and the Etiology of Thrombotic and Hemorrhagic Manifestations in Essential Thrombocythemia and Polycythemia Vera
605
Kadir, Rezan A.; Chi, Claudia: Women and von Willebrand Disease: Controversies in Diagnosis and Management
616
Federici, Augusto B.: Management of Inherited von Willebrand Disease in 2006
621
Berntorp, Erik: Prophylaxis and Treatment of Bleeding Complications in von Willebrand Disease Type 3
626
Budde, Ulrich; Metzner, Hubert J.; Müller, Heinz-Georg: Comparative Analysis and Classification of von Willebrand Factor/Factor VIII Concentrates: Impact on Treatment of Patients with von Willebrand Disease
636
Michiels, Jan J.; Gadisseur, Alain; van der Planken, Marc; Schroyens, Wilfried; van de Velden, Ann; Berneman, Zwi: Guidelines for the Evaluation of Intravenous Desmopressin and von Willebrand Factor/Factor VIII Concentrate in the Treatment and Prophylaxis of Bleedings in von Willebrand Disease Types 1, 2, and 3

LETTER TO THE EDITOR

646
Michiels, Jan Jacques: The Use of Aspirin and Clinical Implications in Essential Thrombocythemia